Switzerland
About Lonza Group AG
Lonza Group AG, together with its subsidiaries, supplies a wide range of products and services for pharmaceutical, biotech, and nutrition markets across Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. Founded in 1897 and headquartered in Basel, Switzerland, Lonza operates through four key segments.
Business Segments
- Biologics: Specializes in contract development and manufacturing of biopharmaceuticals, supporting clinical and commercial needs throughout the product lifecycle, including drug substance and drug product manufacturing.
- Small Molecules: Provides integrated development and manufacturing services for small molecule drug substances and intermediates, along with support in design, particle engineering, and drug product packaging.
- Cell & Gene: Develops technologies for cell and gene therapies, offering contract manufacturing, regulatory support, and platforms like the Cocoon system for automated cell therapy production. Also supplies specialty raw materials for injectable drugs and vaccines.
- Capsules & Health Ingredients: Delivers capsules, dosage form solutions, and health ingredients tailored for pharmaceutical and nutraceutical customers.
With a legacy of innovation since 1897, Lonza continues to be a leader in advancing healthcare solutions worldwide.
